Targets in the FDA's Pediatric Molecular Target Lists (PMTL) are important for studies of pediatric cancer and have special legal requirements associated with drug development. The table below is a computable interpretation of the target lists published by the FDA. See our MTP PMTL Documentation or the official FDA publication for details.
Each target in the list is designated as either a